by 
Artificial kidneys are medical devices that can temporarily or permanently perform the functions of kidneys in patients with renal failure. They are also known as dialysis machines. There are two main types of artificial kidneys – hemodialysis machines and peritoneal dialysis machines. Hemodialysis machines filter the blood using an artificial dialyzer and dialysate solution, while peritoneal dialysis machines use the peritoneal membrane in the abdomen as a natural filter. The global artificial kidney market is currently dominated by hemodialysis machines that find widespread application in hospitals and dialysis centers. These machines are used to treat a condition called end-stage renal disease (ESRD) where the kidneys permanently fail to function. According to estimates, over 2 million people currently suffer from ESRD globally and undergo dialysis as a life-saving treatment. The rising prevalence of chronic kidney diseases and growing geriatric population are contributing to the increasing numbers of ESRD patients, thereby driving the demand for artificial kidneys.
The global Artificial Kidney Market is estimated to be valued at US$ 3358.54 million in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Growing Patient Pool – According to the National Kidney Foundation, approximately 37 million Americans are currently affected by kidney diseases and the numbers are rising. Moreover, about 15% of the global population is affected by chronic kidney disease in its early stages. With inadequate treatment and control, these diseases often progress to end-stage necessitating renal replacement therapies like dialysis and kidney transplantation. The large and growing patient population base serves as a key driver for the artificial kidney market.
Technological Advancements – Renal replacement therapies have advanced significantly over the past decades. New hemodialysis machines now have advanced features like proportionate ultrafiltration control and adaptive ultrafiltration that help increase patient safety and comfort during dialysis. Meanwhile, peritoneal dialysis is moving towards automated and portable systems. Many companies are also researching innovative artificial kidney designs to make the treatment more biocompatible and widely accessible. Continuous technological upgrades are further fueling the demand.
Segment Analysis
The artificial kidney market is segmented into portable and non-portable artificial kidneys. The non-portable segment dominates the market due to the large patient pool undergoing hemodialysis in hospitals and dialysis centers. Portable artificial kidneys are still at an experimental and research stage.
PEST Analysis
Political: Governments across regions are focusing on increasing healthcare spending to strengthen medical infrastructure and offer better treatment options to patients with kidney failure. This is propelling the growth of the artificial kidney market.
Economic: The rising healthcare costs of dialysis and kidney transplants are driving demand for artificial kidneys. Developing economies with large patient pools present lucrative opportunities.
Social: Growing incidence of lifestyle diseases such as diabetes and hypertension leading to kidney failures has increased the social need for innovative renal replacement therapies.
Technological: Advancements in biomaterials, microfluidics, and cell encapsulation techniques are aiding the development of miniaturized implantable bioartificial kidneys. Partnerships between academia and industry are accelerating R&D.
Key Takeaways
The global artificial kidney market is expected to witness high growth. The non-portable artificial kidney segment dominates due to large adoption in hospitals and dialysis centers. The global Artificial Kidney Market is estimated to be valued at US$ 3358.54 million in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031.
Regional analysis comprises
North America leads due to presence of major players like Fresenius, Baxter, and Medtronic catering to the large ESRD patient base. Asia Pacific is poised to be the fastest growing region on account of the growing burden of CKD along with increasing healthcare expenditure.
Key players operating in the artificial kidney market are KAWASUMI LABORATORIES, INC., Nanodialysis, Fresenius SE & Co KGaA, Baxter, ASAHI KASEI MEDICAL CO., LTD, Medtronic, DaVita Inc, Merit Medical Systems, Nipro Medical Corporation, Nikkiso Co Ltd, Braun Melsungen AG and AWAK Technologies. Fresenius and Baxter are established dialysis product manufacturers focusing on engineering localized implantable bioartificial kidneys. Early-stage companies are leveraging technologies to develop miniaturized portable devices.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
